FibroGen Inc (FGEN) stock is lower by -55.75% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives FGEN stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 6. FGEN's rank also includes a long-term technical score of 45. The fundamental score for FGEN is 47. In addition to the average rating from Wall Street analysts, FGEN stock has a mean target price of $14.50. This means analysts expect the stock to climb 61.65% over the next 12 months. FGEN has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on FGEN!